Goblet cell carcinoid

What is the long-term outlook for individuals with goblet cell carcinoid?

In general, 76% of individuals who are diagnosed with goblet cell carcinoid live at least five years after being diagnosed. Important factors to consider when determining prognosis include the size and location of the tumor, and whether or not the cancer has spread to other parts of the body. If cancer cells have spread to distant parts of the body, the chances of survival are decreased.

Last updated on 05-01-20

How might goblet cell carcinoid be treated?

Surgical resection (removing the abnormal tissue) is the primary treatment for goblet cell carcinoid (GCC). However, due to the condition's rarity, there is a lack of ample evidence or general consensus regarding the extent to which resection should be performed for different stages of this condition.

Because of the typical course of the condition and the malignant nature of the tumors, treatment recommendations are more similar to that of adenocarcinomas rather than most carcinoids. Stage I tumors may be treated with appendectomy alone. However, in higher stages, a right hemicolectomy (RH) is the most commonly recommended surgical option despite controversy in the medical community. The justification for RH is to do adequate nodal sampling (when samples are taken to check for more cancer) because metastasis is common. Some researches have reported a lack of benefit from extensive surgery provided there is no nodal involvement. It has also been reported by some researchers that in patients studied, the 5-year survival rates were not significantly different between those treated with appendectomy and those who underwent RH. Careful follow-up after surgery is highly recommended and may include periodic physical examinations, blood testing, and imaging studies. In some cases, adjuvant chemotherapy is also recommended.

We are unable to give advice to individuals regarding the best course of treatment. We recommend speaking with your health care provider to discuss treatment options.

Last updated on 05-01-20

Where To Start

Carcinoid Cancer Foundation

The Carcinoid Cancer Foundation, Inc. has an information page on carcinoid tumors and related neuroendocrine tumors. Click on Carcinoid Cancer Foundation, Inc. to view the information page.

Last updated on 04-27-20

American Cancer Info page pg goblet cell carcinoma

The American Cancer Society has an information page on gastrointestinal carcinoid tumor. Click on American Cancer Society to view the information page.

Last updated on 04-27-20

Name: American Cancer Society 250 Williams Street NW
Atlanta, GA, 30329, United States
Toll Free: 1-800-227-2345 Url: https://www.cancer.org
Name: Carcinoid Cancer Foundation 333 Mamaroneck Avenue Suite 492
White Plains, NY, 10605 , United States
Phone: +1-914-683-1001 Toll Free: 1-888-722-3132 Fax : +1-914-683-5919 Url: https://www.carcinoid.org/
Name: Neuroendocrine Tumor Research Foundation NETRF 321 Columbus Avenue, Suite 5R
Boston, MA, 02116 , United States
Phone: +1-617-946-1780 Email: info@netrf.org Url: https://netrf.org/
Name: Appendix Cancer/Pseudomyxoma Peritonei Research Foundation ACPMP Research Foundation 2021 L Street NW Suite 101-244
Washington, DC, 20036-4909, United States
Phone: 833-227-6773 Email: info@acpmp.org Url: https://acpmp.org/
Name: Carcinoid NeuroEndocrine Tumour Society Canada CNETS Canada 1608 Blakely Drive
Cornwall, Ontario, K6J 5P4, Canada
Phone: +1-416-628-3189 Toll Free: 1-844-628-6788 Email: info@cnetscanada.org,support@cnetscanada.org Url: https://cnetscanada.org/

Connect with other users with Goblet cell carcinoid on the RareGuru app

Do you have information about a disease, disorder, or syndrome? Want to suggest a symptom?
Please send suggestions to RareGuru!

The RareGuru disease database is regularly updated using data generously provided by GARD, the United States Genetic and Rare Disease Information Center.

People Using the App

Join the RareGuru Community

To connect, share, empower and heal today.

People Using the App